Correlation Between Incyte and AstraZeneca PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Incyte and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Incyte and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Incyte and AstraZeneca PLC ADR, you can compare the effects of market volatilities on Incyte and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Incyte with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Incyte and AstraZeneca PLC.

Diversification Opportunities for Incyte and AstraZeneca PLC

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Incyte and AstraZeneca is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Incyte and AstraZeneca PLC ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC ADR and Incyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Incyte are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC ADR has no effect on the direction of Incyte i.e., Incyte and AstraZeneca PLC go up and down completely randomly.

Pair Corralation between Incyte and AstraZeneca PLC

Given the investment horizon of 90 days Incyte is expected to generate 1.96 times more return on investment than AstraZeneca PLC. However, Incyte is 1.96 times more volatile than AstraZeneca PLC ADR. It trades about 0.2 of its potential returns per unit of risk. AstraZeneca PLC ADR is currently generating about 0.24 per unit of risk. If you would invest  5,408  in Incyte on March 7, 2024 and sell it today you would earn a total of  449.00  from holding Incyte or generate 8.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Incyte  vs.  AstraZeneca PLC ADR

 Performance 
       Timeline  
Incyte 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Incyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Incyte is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
AstraZeneca PLC ADR 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in AstraZeneca PLC ADR are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, AstraZeneca PLC displayed solid returns over the last few months and may actually be approaching a breakup point.

Incyte and AstraZeneca PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Incyte and AstraZeneca PLC

The main advantage of trading using opposite Incyte and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Incyte position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.
The idea behind Incyte and AstraZeneca PLC ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios